Clinical trial
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing…
NCT00498550 · Dartmouth-Hitchcock Medical Center, Other · Completed
Key facts
| NCT number | NCT00498550 |
|---|---|
| Title | Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual |
| Official title | Cannabis and Schizophrenia: Effects of Clozapine |
| Lead sponsor | Dartmouth-Hitchcock Medical Center, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH University of Missouri, Kansas City VA Medical Center-West Los Angeles U.S. Fed University of South Carolina |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Dual Diagnosis, Schizoaffective Disorder, Psychotic Disorder, Cannabis Abuse |
| Intervention type | Drug |
| Interventions | Clozapine, Treatment as usual |
| Enrollment | 31 |
| Start date | Oct 1, 2000 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Jul 10, 2007 |
| Last update posted | Mar 13, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: